Here's a roadmap for sourcing across borders during uncertain times.

China’s aggressive campaign to bring down drug prices is leading to a “vicious cycle” and will prevent the emergence of a national pharmaceutical champion, said one of the country’s biggest drug makers.

Alphabet Inc. offshoot Wing, which just received an expanded certification to act as a small air carrier, is starting the nation’s inaugural delivery service via a small civilian aircraft with partners Walgreens and FedEx.

While most business leaders want to avoid a no-deal departure, continued uncertainty is not much better. With the cliff edge looming, and the prospect of another one in three months if the EU grants Parliament’s request for a further delay, collateral damage is mounting.

Given that Johnson & Johnson’s lawyers made public statements this month that the company’s talc-based products were free of asbestos, the recall couldn’t come at a worse time.

The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.

Medical cannabis producers have a five-year window to reap high prices for their products before supply floods the market.

A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.

Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.

Faced with a worsening epidemic of teenage vaping and a mysterious illness stalking users of cigarette alternatives, the Trump administration promised to ratchet up its oversight of a burgeoning but increasingly troubled industry.